Alkyne-substituted pyridone compounds and methods of use

Details for Australian Patent Application No. 2007272830 (hide)

Owner Amgen Inc.

Inventors White, Ryan

Agent Shelston IP

Pub. Number AU-B-2007272830

PCT Pub. Number WO2008/008493

Priority 60/831,088 14.07.06 US

Filing date 13 July 2007

Wipo publication date 17 January 2008

Acceptance publication date 28 July 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/008493 Priority application(s): WO2008/008493

28 July 2011 Application Accepted

  Published as AU-B-2007272830

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272839-4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

2007272824-Gene expression profiling for identification, monitoring and treatment of multiple sclerosis